Business Segments · Research and development expenses
MedSurg — Research and development expenses
Boston Scientific MedSurg — Research and development expenses increased by 7.8% to $138.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $128.00M to $138.00M. Over 3 years (FY 2022 to FY 2025), MedSurg — Research and development expenses shows an upward trend with a 5.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
Higher spending indicates a strong focus on long-term growth and pipeline development.
Detailed definition
Costs incurred by the MedSurg segment for the research, development, and clinical testing of new medical devices and tec...
Peer comparison
Standard R&D investment metric for technology-driven medical device firms.
Metric ID:
bsx_segment_medsurg_research_and_development_expensesHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $108.00M | $108.00M | $108.00M | $108.00M | $106.75M | $106.75M | $106.75M | $106.75M | $107.00M | $114.00M | $113.00M | $128.00M | $121.00M | $120.00M | $128.00M | $138.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -1.2% | +0.0% | +0.0% | +0.0% | +0.2% | +6.5% | -0.9% | +13.3% | -5.5% | -0.8% | +6.7% | +7.8% |
| YoY Change | — | — | — | — | -1.2% | -1.2% | -1.2% | -1.2% | +0.2% | +6.8% | +5.9% | +19.9% | +13.1% | +5.3% | +13.3% | +7.8% |
Range$106.75M – $138.00M
CAGR+6.8%
Avg YoY Growth+5.6%
Median YoY Growth+5.6%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — research and development expenses?
- Boston Scientific (BSX) reported medsurg — research and development expenses of $138.00M in Q4 2025.
- How has Boston Scientific's medsurg — research and development expenses changed year-over-year?
- Boston Scientific's medsurg — research and development expenses increased by 7.8% year-over-year, from $128.00M to $138.00M.
- What is the long-term trend for Boston Scientific's medsurg — research and development expenses?
- Over 3 years (2022 to 2025), Boston Scientific's medsurg — research and development expenses has grown at a 5.5% compound annual growth rate (CAGR), from $432.00M to $507.00M.
- What does medsurg — research and development expenses mean?
- The total investment in research and development for new products within the MedSurg segment.